Schedule 13G ownership disclosure

Celldex Therapeutics, Inc.

Security class unavailable · CUSIP: 15117B103

Event date: 2014-12-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,298,678
Percent of class
10.3800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000728889-14-001500
Form type
SC 13G
Filer
CELLDEX THERAPEUTICS INC
CIK
CIK 1286517
Filed
Dec 04, 2014
Reporting period
Dec 02, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub